JAMES MARTIN: Open Payments
NPI 1801484548 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$847 in 36 payments from 16 companies in 2025. Trend: 2023 $162 · 2024 $229 · 2025 $847
Food & beverage: $747Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $158 |
| Novartis Pharmaceuticals Corporation | 5 | $130 |
| GENZYME CORPORATION | 4 | $124 |
| PFIZER INC. | 4 | $82 |
| ABBVIE INC. | 3 | $63 |
| Arcutis Biotherapeutics, Inc. | 2 | $46 |
| Amgen Inc. | 2 | $36 |
| Galderma Laboratories, L.P. | 2 | $34 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $27 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $25 |
Products named: TREMFYA, DUPIXENT, CIBINQO, COSENTYX, SKYRIZI, Zoryve, Otezla, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
